FacebookTwitterRedditEmail

Obama’s Latest FDA Nominee: No Hidden Big Pharma Links, They Are All in Plain Sight

The FDA has been called an arm of the drug industry because of how often it smiles on questionable new drugs and new drug approvals only to issue greater warnings or even withdraw them after the drugs made billions. Remember Vioxx, Baycol, Trovan, Meridia, Seldane, Hismanal and Darvon? They are not around anymore. Why? Remember how popular statins, brand name asthma and psychiatric drugs and GERD drugs were? Once they went off patent, the FDA “discovered” serious side effects and began to list warnings. Sorry about that.

There is a stereotype of backwoods courtroom “justice” in which prosecutors and defense attorneys who appeared to be adversarial leave arm in arm and go for a beer after a judicial decision. No hard feelings. The same collegiality oozes at FDA hearings with FDA staffers seeming to suck up to industry, perhaps for jobs in which they return to squeeze their prior colleagues. (Who remembers former Texas Governor Rick Perry’s chief of staff leaning on Perry to vaccinate all the state’s girls with the Merck vaccine Gardasil after he left for industry?)

FDA advisory panels, whose recommendations the FDA usually follows, are supposed to include “patient representatives” to see that the public’s interests are balanced against Big Pharma consultants. So many doctors and researchers now live on 5 and 6 digit drug company stipends, the FDA actually relaxed conflict of interest rules a few years ago–it could not find enough unlinked doctors!

But the “patient representatives” can be a sham. At one meeting I attended, one “patient representative” was a member of the drug industry-funded National Alliance on Mental Illness (NAMI) which was investigated by Congress for its hidden Pharma income and many consider a front group. The other so-called patient representative” had given keynote speeches at NAMI. So much for transparency.

Because of the huge amount of money to be made from a blockbuster drug like Lipitor—it was the best selling drug in the world—there is a natural tension between drug companies who want to hurry the march to Wall $treet and drug regulators who want to slow it down to protect the public.

That is why the nomination of unapologetic drug industry supporter, Robert M. Califf, for FDA Commissioner is so concerning. A disclosure statement on the website of Duke Clinical Research Institute list 25 drug companies Califf receives “research” funds from including drug giants like Johnson & Johnson, Lilly, Merck, Schering Plough and GSK.

Califf has gone on record that collaboration between industry and regulators is a good thing.  He told NPR, “Many of us consult with the pharmaceutical industry, which I think is a very good thing. They need ideas and then the decision about what they do is really up to the person who is funding the study.” What?

He is known for defending Vioxx which is reported to have caused at least 50,000 heart attacks and events before its withdrawal. (Merck is said to have known about Vioxx’ cardio effects but marketed the blockbuster drug anyway.)

Califf was instrumental in the Duke drug trial of the blood thinner Xarelto and a cheerleader of the drug despite medical experts’ objections to its approval and 379 subsequent deaths. Duke, where Califf directed clinical research, is still recovering from a major research fraud scandal that resulted in terminated grants, retracted papers and a Sixty Minutes special. It is the least appropriate place from which to choose an FDA Commissioner.

If approved as FDA Commissioner, as many expect, will Califf recuse himself from decisions on the dozens of drugs whose manufacturers pay him? Or will he rule on them anyway? Either way, his nomination is a slap in the face of every honest doctor, researcher and regulator and the public that puts its trust in the FDA. In fact, if the FDA Commissioner is funded by industry, why have an FDA?

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

bernie-the-sandernistas-cover-344x550
Weekend Edition
December 13, 2019
Friday - Sunday
Melvin Goodman
The FBI: Another Worry in the National Security State
Rob Urie
Establishment Politics are for the Rich
Jeffrey St. Clair
Roaming Charges: That’s Neoliberalism for You
Paul Street
Midnight Ramble: A Fascist Rally in Hershey, Pennsylvania
Joan Roelofs
The Science of Lethality
Joyce Nelson
Buttigieg and McKinsey
Joseph Natoli
Equally Determined: To Impeach/To Support
Charles Pierson
The National Defense Authorization Act Perpetuates the Destruction of Yemen
REZA FIYOUZAT
An Outrageous Proposal: Peace Boats to Iran
Lee Hall
Donald Trump Jr., Mongolian Sheep Killer
Andrew Levine
A Plague on Both Their Houses, Plus a Dozen Poxes on Trump’s
David Rosen
Mortality Rising: Trump and the Death of the “American Dream”
Dave Lindorff
The Perils of Embedded Journalism: ‘Afghan Papers’ Wouldn’t Be Needed If We Had a Real Independent News Media
Brian Cloughley
Human Rights and Humbug in Washington
Stephen Leas
Hungry for a Livable Planet: Why I Went On Hunger Strike and Occupied Pelosi’s Office
Saad Hafiz
Pakistan Must Face Its Past
Lawrence Davidson
Deteriorating Climates: Home and Abroad
Cal Winslow
The End of the Era: Nineteen Nineteen
Louis Proyect
If Time Magazine Celebrates Greta Thunberg, Why Should We?
Thomas Drake
Kafka Down Under: the Threat to Whistleblowers and Press Freedom in Australia
Thomas Knapp
JEDI Mind Tricks: Amazon Versus the Pentagon and Trump
Jesse Jackson
Trump’s War on the Poor
Michael Welton
Seeing the World Without Shadows: the Enlightenment Dream
Ron Jacobs
The Wind That Shook the Barley: the Politics of the IRA
Rivera Sun
Beyond Changing Light Bulbs: 21 Ways You Can Stop the Climate Crisis
Binoy Kampmark
The Bloomberg Factor: Authoritarianism, Money and US Presidential Politics
Nick Pemberton
Ideology Shall Have No Resurrection
Rev. Susan K. Williams Smith
What Trump and the GOP Learned From Obama
Ramzy Baroud
‘Elected by Donors’: the University of Cape Town Fails Palestine, Embraces Israel
Cesar Chelala
Unsuccessful U.S. Policy on Cuba Should End
Harry Blain
The Conservatism of Impeachment
Norman Solomon
Will the Democratic Presidential Nomination Be Bought?
Howard Lisnoff
The One Thing That US Leaders Seem to Do Well is Lie
Jeff Cohen
Warren vs. Buttigieg Clash Offers Contrast with Sanders’ Consistency
Mel Gurtov
The Afghanistan Pentagon Papers
Gaither Stewart
Landslide … to Totalitarianism
Kollibri terre Sonnenblume
How Blaming Nader in 2000 Paved the Way for Today’s Neo-Fascism
Steve Early
In Re-Run Election: LA Times Journalist Wins Presidency of NewsGuild 
David Swanson
If You’re Not Busy Plotting Nonviolent Revolution for Peace and Climate, You’re Busy Dying
Nicky Reid
Sorry Lefties, Your Impeachment is Bullshit
John Kendall Hawkins
The Terror Report You Weren’t Meant to See
Susan Block
Krampus Trumpus Rumpus
Martin Billheimer
Knight Crawlers
David Yearsley
Kanye in the West
Elliot Sperber
Dollar Store 
FacebookTwitterRedditEmail